NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 23 | +6 |
| Shares | 1.64M | 320 | 1.75M | +114.0K (+7.0%) |
| Value | $18.9M | $4.00K | $16.2M | −$2.70M (−14.3%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 153,523 | $1.42M | 0.01% |
| Citadel Advisors LLC | 135,087 | $1.25M | 0.00% |
| Jane Street Group, LLC | 77,032 | $714.0K | 0.00% |
| Susquehanna International Group, LLP | 55,328 | $513.0K | 0.00% |
| Bank of America Corp | 19,362 | $179.0K | 0.00% |
| Murchinson Ltd. | 17,900 | $166.0K | 0.08% |
| Group One Trading, L.P. | 7,574 | $70.0K | 0.00% |
| Cutler Group LP | 7,451 | $69.0K | 0.01% |
| Wells Fargo & Company | 5,000 | $46.0K | 0.00% |
| Penserra Capital Management LLC | 2,956 | $27.0K | 0.00% |
| Quantbot Technologies LP | 1,565 | $14.0K | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $9.00K | 0.00% |
| JPMorgan Chase & Co | 212 | $2.00K | 0.00% |
| Larson Financial Group LLC | 218 | $2.00K | 0.00% |
Sold out (8)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Linden Advisors LP | 364,352 | $4.23M |
| Northern Trust Corp | 130,633 | $1.52M |
| Ionic Capital Management LLC | 35,721 | $415.0K |
| Yakira Capital Management, Inc. | 11,923 | $139.0K |
| UBS Group AG | 8,385 | $97.0K |
| Royal Bank of Canada | 8,000 | $93.0K |
| Deutsche Bank AG | 200 | $2.00K |
| Stonebridge Financial Planning Group, LLC | 80 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 320 | $4.00K |